共 50 条
- [28] Correction to: Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study [J]. Translational Neurodegeneration, 9
- [30] Hepatic safety of opicapone in Parkinson's disease patients [J]. MOVEMENT DISORDERS, 2015, 30 : S101 - S101